Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.829 SEK | +6.28% | +1.38% | +17.56% |
May. 06 | Transcript : Alligator Bioscience AB, Q1 2024 Earnings Call, May 06, 2024 | |
May. 06 | Alligator Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 261M 24.03M | Sales 2025 * | 122M 11.26M | Capitalization | 591M 54.4M |
---|---|---|---|---|---|
Net income 2024 * | -6M -552K | Net income 2025 * | -89M -8.19M | EV / Sales 2024 * | 0.75 x |
Net cash position 2024 * | 395M 36.3M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.83 x |
P/E ratio 2024 * |
-1.71
x | P/E ratio 2025 * |
-7.78
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.28% |
Latest transcript on Alligator Bioscience AB
1 day | +1.28% | ||
1 week | -1.13% | ||
Current month | -12.22% | ||
1 month | -25.47% | ||
3 months | -23.75% | ||
6 months | +88.32% | ||
Current year | +14.66% |
Managers | Title | Age | Since |
---|---|---|---|
Søren Bregenholt
CEO | Chief Executive Officer | 53 | 21-05-31 |
Marie Svensson
DFI | Director of Finance/CFO | 60 | 20-08-31 |
Chief Tech/Sci/R&D Officer | 56 | 22-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 70 | 16-12-31 | |
Staffan Encrantz
BRD | Director/Board Member | 73 | 22-05-08 |
Director/Board Member | 62 | 21-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 0.81 | +3.85% | 1 008 021 |
24-05-13 | 0.78 | +0.39% | 1,334,258 |
24-05-10 | 0.777 | -7.94% | 1,917,432 |
24-05-08 | 0.844 | +5.63% | 575,008 |
24-05-07 | 0.799 | -5.44% | 3,293,377 |
Delayed Quote Nasdaq Stockholm, May 14, 2024 at 07:59 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.66% | 54.52M | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+45.09% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- ATORX Stock